Marçal Yll, Francisco Rodríguez-Frías, Maria Buti, David Tabernero, Rafael Esteban-Mur, Selene García-García, Beatriz Pacín Ruiz, Rosa Lopez-Martinez, Ariadna Rando, Josep Quer, Maria Francesca Cortese, Sara Sopena, Cristina Godoy, Mar Riveiro-Barciela, Mercedes Guerrero-Murillo, Luca Carioti, Rosario Casillas, Josep Gregori, Carolina González
Journal: Scientific reports 2021;11(1):4215
PMID: 33603102
Patients with HBeAg-negative chronic infection (CI) have not been extensively studied because of low viremia. The HBx protein, encoded by HBX, has a key role in viral replication. Here, we analyzed the viral quasispecies at the 5' end of HBX in CI patients and compared it with that of patients in other clinical stages. Fifty-eight HBeAg-negative patients were included: 16 CI, 19 chronic hepatitis B, 16 hepatocellular carcinoma and 6 liver cirrhosis. Quasispecies complexity and conservation were determined in the region between nucleotides 1255 and 1611. Amino acid changes detected were tested in vitro. CI patients showed higher complexity in terms of mutation frequency and nucleotide diversity and higher quasispecies conservation (p < 0.05). A genotype D-specific pattern of mutations (A12S/P33S/P46S/T36D-G) was identified in CI (median frequency, 81.7%), which determined a reduction in HBV DNA release of up to 1.5 log in vitro. CI patients showed a more complex and conserved viral quasispecies than the other groups. The genotype-specific pattern of mutations could partially explain the low viremia observed in these patients.
Full Text Sources:
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.